An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term efficacy and safety of a long-acting
injectable formulation of risperidone (an antipsychotic medication) and its influence on
quality of life, in participants with schizophrenia (psychiatric disorder with symptoms of
emotional instability, detachment from reality, often with delusions and hallucinations, and
withdrawal into the self).